Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-19

Clinical Trial Update: Effects of Sulforaphane on Cognitive Function in Patients With Frontal Brain Damage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effects of sulforaphane on cognitive function in patients with frontal brain damage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulforaphane (sulforaphane)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Frontal Lobe Dysfunction | Phase 2 | Status: UNKNOWN